MedPath

Choice of Palliative Procedures for Pulmonary Atresia With Ventricular Septal Defect Patients

Not Applicable
Completed
Conditions
Pulmonary Atresia With Ventricular Septal Defect
Tetralogy of Fallot With Pulmonary Atresia
Interventions
Procedure: Systemic-to-pulmonary artery shunts
Registration Number
NCT02861963
Lead Sponsor
Meshalkin Research Institute of Pathology of Circulation
Brief Summary

The aim is to compare effective growth true hypoplastic pulmonary arteries using Right Ventricle Outflow Tract Reconstruction by femoral allogenic vein valve conduit and systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt)

Detailed Description

The use of femoral allogenic vein valve conduit for Right Ventricle Outflow Tract Reconstruction is good alternative systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt). Main advantages is straight, symmetrical, pulsating, systolic blood flow in hypoplastic pulmonary artery, which stimulate growth and prepares for a radical repair. Taking into account the absence randomized studies in this area of medicine, providing investigation evaluating parameters of safety for both methodics is very actual.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Systemic-to-pulmonary artery shuntsSystemic-to-pulmonary artery shuntssystemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt)
Primary Outcome Measures
NameTimeMethod
Growth of pulmonary arteriesFrom 6 to 12 months

-Index Nakata ≥ 150 mm/m2

Secondary Outcome Measures
NameTimeMethod
Number of further re interventions1 year

* catheterization

* balloon plastic of the pulmonary arteries with stenting

* unification procedures

Complications1 year

* pulmonary arteries stenosis

* Thrombosis

* Bleeding

* Death

* Vein graft dysfunction

Trial Locations

Locations (1)

Novosibirsk State Research Institute of Circulation Pathology

🇷🇺

Novosibirsk, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath